The aim of this work is twofold: to identify specific dysfunctions of the brain network that occur in a well-characterized AD mouse model, i.e., the B6.152H line, before and after plaque deposition, and to disentangle the specific contribution of mutations in PS2 and APP. This evidence concerns the gene PSEN2 and Alzheimer disease.